Clinical Trial Information A Randomized, Double Blind Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500-1500g Birth Weight in the Prevention of Necrotizing Enterocolitis Protocol Number: 10928 Status: Open Age Group: Children Treatment Type: Prevention Phase: III NCT ID: NCT03978000 Scope Information Scope: National Disease Site(s): Other
